ReviewBiosensors2026
From Device-Level Implementation to In-Sensor Computing in Memristive-Device-Based Biosensors: A Review.
Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Memristive devices have attracted considerable attention as promising candidates for overcoming the energy and data-transfer limitations of conventional computing architectures. In particular, their integration with biosensors offers a pathway toward compact and energy-efficient diagnostic systems. This review examines the development of memristive-device-based biosensors from device-level transduction to system-level integration. At the device level, sensing strategies have evolved from direct sensing toward indirect sensing architectures, improving stability and reusability. At the system level, conventional off-chip implementations have progressively shifted toward fully integrated on-chip implementations. Furthermore, this review highlights the emerging paradigm of in-sensor computing, in which sensing, memory, and computation are co-located within a single physical platform. This approach enables reduced data movement and supports energy-efficient operation for point-of-care applications. Finally, key challenges-including CMOS compatibility, device variability, and reliable multi-threshold sensing operation-are discussed as critical factors for the practical realization of memristive-device-based electrochemical biosensing systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.